These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 25396764)

  • 21. Prophylaxis vs. on-demand treatment with Nuwiq(®) (Human-cl rhFVIII) in adults with severe haemophilia A.
    Tiede A; Oldenburg J; Lissitchkov T; Knaub S; Bichler J; Manco-Johnson MJ
    Haemophilia; 2016 May; 22(3):374-80. PubMed ID: 26582282
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Major bleeding disorders: diagnosis, classification, management and recent developments in haemophilia.
    Bhatnagar N; Hall GW
    Arch Dis Child; 2018 May; 103(5):509-513. PubMed ID: 29175823
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Similar bleeding phenotype in young children with haemophilia A or B: a cohort study.
    Clausen N; Petrini P; Claeyssens-Donadel S; Gouw SC; Liesner R;
    Haemophilia; 2014 Nov; 20(6):747-55. PubMed ID: 24893572
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Prophylaxis in patients with haemophilia complicated by inhibitors].
    Paweł Ł
    Pol Merkur Lekarski; 2011 Mar; 30(177):211-4. PubMed ID: 21545000
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hemophilia and prophylaxis.
    Ljung R
    Pediatr Blood Cancer; 2013; 60 Suppl 1():S23-6. PubMed ID: 23109472
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Current situation of regular replacement therapy (prophylaxis) for haemophilia in Japan.
    Taki M; Shirahata A
    Haemophilia; 2009 Jan; 15(1):78-82. PubMed ID: 18700841
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Absence of correlation between X chromosome inactivation pattern and plasma concentration of factor VIII and factor IX in carriers of haemophilia A and B.
    Orstavik KH; Scheibel E; Ingerslev J; Schwartz M
    Thromb Haemost; 2000 Mar; 83(3):433-7. PubMed ID: 10744150
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optimizing factor prophylaxis for the haemophilia population: where do we stand?
    Blanchette VS; Manco-Johnson M; Santagostino E; Ljung R
    Haemophilia; 2004 Oct; 10 Suppl 4():97-104. PubMed ID: 15479380
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Promising coagulation factor VIII bypassing strategies for patients with haemophilia A.
    Duan X; Tang M; Zhang J; Yu H; Xu R
    Blood Coagul Fibrinolysis; 2014 Sep; 25(6):539-52. PubMed ID: 24614429
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of joint bleeding in hemophilia.
    Simpson ML; Valentino LA
    Expert Rev Hematol; 2012 Aug; 5(4):459-68. PubMed ID: 22992238
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An open clinical study assessing the efficacy and safety of Factor IX Grifols, a high-purity Factor IX concentrate, in patients with severe haemophilia B.
    Lissitchkov T; Matysiak M; Zawilska K; Gercheva L; Antonov A; Montañes M; Paez A
    Haemophilia; 2010 Mar; 16(2):240-6. PubMed ID: 20015218
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An analysis of factors affecting the incidence of inhibitor formation in patients with congenital haemophilia in Japan.
    Shirahata A; Fukutake K; Higasa S; Mimaya J; Oka T; Shima M; Takamatsu J; Taki M; Taneichi M; Yoshioka A;
    Haemophilia; 2011 Sep; 17(5):771-6. PubMed ID: 21682824
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [French guidelines. Long-term prophylaxis for severe haemophilia A and B children to prevent haemophiliac arthropathy].
    Meunier S; Trossaërt M; Berger C; Borel-Derlon A; Dirat G; Donadel-Claeyssens S; Assolant AD; Guérois C; Lutz P; Rafowicz A; Rothschild C; Chambost H;
    Arch Pediatr; 2009 Dec; 16(12):1571-8. PubMed ID: 19960603
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A synopsis of current haemophilia care in Hong Kong.
    Au WY; Lee V; Kho B; Ling AS; Chan D; Chan EY; Chan GC; Cheung WW; Lau CW; Lee CY; Li RC; Li CK; Lin SY; Mak V; Sun L; Wong KH; Wong R; Yau J; Yuen HL
    Hong Kong Med J; 2011 Jun; 17(3):189-94. PubMed ID: 21636866
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Once-weekly prophylactic treatment vs. on-demand treatment with nonacog alfa in patients with moderately severe to severe haemophilia B.
    Kavakli K; Smith L; Kuliczkowski K; Korth-Bradley J; You CW; Fuiman J; Zupančić-Šalek S; Abdul Karim F; Rendo P
    Haemophilia; 2016 May; 22(3):381-8. PubMed ID: 26823276
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparison of the treatment of patients with factor IX deficiency to that of those with factor VIII deficiency: results of an International Survey conducted as part of the International FIX Treatment Network.
    Berntorp E; Shapiro AD; Waters J; Astermark J
    Haemophilia; 2014 Sep; 20(5):e362-4. PubMed ID: 25156443
    [No Abstract]   [Full Text] [Related]  

  • 37. Modern haemophilia care.
    Berntorp E; Shapiro AD
    Lancet; 2012 Apr; 379(9824):1447-56. PubMed ID: 22456059
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Severe and moderate haemophilia A and B in US females.
    Di Michele DM; Gibb C; Lefkowitz JM; Ni Q; Gerber LM; Ganguly A
    Haemophilia; 2014 Mar; 20(2):e136-43. PubMed ID: 24533955
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Describing the quality of life of boys with haemophilia in China: Results of a multicentre study using the CHO-KLAT.
    Tang L; Xu W; Li CG; Hou F; Feng XQ; Wang H; Li XJ; Li WL; Liu JP; Sun LR; Wang SH; Jin J; Fang Q; Luke KH; Poon MC; Blanchette VS; Usuba K; Young NL; Wu R
    Haemophilia; 2018 Jan; 24(1):113-119. PubMed ID: 28922525
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Joint WFH-ISTH session: issues in clinical trial design.
    Peyvandi F; Farrugia A; Iorio A; Key NS; Srivastava A
    Haemophilia; 2014 May; 20 Suppl 4():137-44. PubMed ID: 24762289
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.